Clinical Trial
doi: 10.1007/BF01642091.
Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results
- PMID: 881259
- DOI: 10.1007/BF01642091
Item in Clipboard
Clinical Trial
Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results
Infection.
1977.
No abstract available
Similar articles
-
Protocol for an evaluative study of the protective effect of isolation systems and decontamination in patients with high susceptibility to infection.Eur J Cancer (1965). 1972 Aug;8(4):367-71. doi: 10.1016/0014-2964(72)90118-1. Eur J Cancer (1965). 1972. PMID: 5073299 No abstract available.
-
[Effectiveness of gnotobiotic measures in the treatment of acute leukemia: the results of a prospective randomized clinical study].Onkologie. 1979 Jun;2(3):102-7. doi: 10.1159/000214484. Onkologie. 1979. PMID: 392375 Clinical Trial. German.
-
Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukaemia patients. III: The quality of isolation and decontamination.Infection. 1978;6(4):175-91. doi: 10.1007/BF01641908. Infection. 1978. PMID: 689746 Clinical Trial.
-
[Treatment of cancer and counter-measures for MRSA infections].Gan To Kagaku Ryoho. 1994 Mar;21(4):409-16. Gan To Kagaku Ryoho. 1994. PMID: 8129380 Review. Japanese.
-
[Empirical antimicrobial therapy in a patient with neutropenia].Duodecim. 2002;118(21):2241-7. Duodecim. 2002. PMID: 12486961 Review. Finnish. No abstract available.
Cited by
-
Infection in acute leukemia patients receiving oral nonabsorable antibiotics.Antimicrob Agents Chemother. 1978 Jun;13(6):958-64. doi: 10.1128/AAC.13.6.958. Antimicrob Agents Chemother. 1978. PMID: 98107 Free PMC article.
-
Prevention of infection in children with acute leukaemia. No major difference between total and selective bowel decontamination.Support Care Cancer. 1996 May;4(3):200-6. doi: 10.1007/BF01682341. Support Care Cancer. 1996. PMID: 8739653
-
Salivary concentrations of amphotericin B following its use as an oral lozenge.Infection. 1980;8(2):63-5. doi: 10.1007/BF01639148. Infection. 1980. PMID: 6993365
-
Amphotericin B concentrations in saliva after application of 2% amphotericin B in orabase.Infection. 1978;6(1):16-20. doi: 10.1007/BF01641085. Infection. 1978. PMID: 631898
-
Preventing infection in neutropenic cancer patients.West J Med. 1983 May;138(5):690-8. West J Med. 1983. PMID: 6880186 Free PMC article. No abstract available.